Not Signed In - Relate
Blood Sugar; Diabetes Mellitus; Non-Insulin Dependent Diabetes Mellitus; Type II Diabetes |
Diabeta; Glynase; Micronase | |
|
|
Pictures
Diabetes Medication Warnings Glyburide Metformin
Several times daily medications to handle my Type 2 Diabetes These are the warning labels on the bottles Fun stuff Lately the medication hasn t been working consistently It looks as if insulin might be another option UPDATE 20080108 Diagnosed now as type 1 on insulin pump and have never felt better A1C at 6 1 with an average glucose of 109 SWEET
avandia slows progression type 2 diabetes jpg
By Laura Watson a recent study proves that avandia is better at slowing the progress of type 2 diabetes than metformin or glyburide A new study shows that Avandia a drug manufactured by drug manufacturing giant GlaxoSmithKline slows down the progression of type 2 diabetes in diabetics with the form of the disease Two
figure4 png
patients with type 2 diabetes continuing on glyburide therapy switched to metformin or given metformin as add on therapy to glyburide Data from
glyburide metfomrin hydrochloride tablet1 jpg
hexylurea Glyburide is a white to off white crystalline compound with a molecular formula of C23H28ClN3O5S and a molecular weight of 494 00 The structural formula is represented below Metformin hydrochloride is an oral antihyperglycemic drug used in the management of type 2 diabetes Metformin hydrochloride N N dimethylimidodicarbonimidic diamide monohydrochloride is not
figure4 png
patients with type 2 diabetes continuing on glyburide therapy switched to metformin or given metformin as add on therapy to glyburide Data from
glyburide jpg
icon glyburide jpg
figure1 png
® 7 pioglitazone hydrochloride Actos® 8 rosiglitazone malate Avandia® 9 acarbose Precose® Glucobay® 10 miglitol Glyset® The actions of sulfonylureas and meglitinides involve the stimulation of insulin secretion metformin suppresses hepatic glucose production the
slide63 jpg
8 both of the pathophysiologic defects that are contributing to the hypoglycemia are present and therefore combination therapy addressing these multiple defects will be more appropriate Slide Glyburide Metformin Initial Therapy Mean Final Doses A study was recently undertaken comparing glyburide as monotherapy metformin as monotherapy with two different dosage strengths of
slide68 jpg
of symptomatic hypoglycemia in patients taking the lowest strength combination tablet was the same as metformin and placebo if the initial HbA1c at entry into the study was above 8 Slide Glyburide Metformin Open Label Initial Therapy for HbA1c >11 or FPG >240 mg dL There were no episodes of severe hypoglycemia And I should add that the incidence of gastrointestinal
slide65 jpg
Initial Therapy Change from Baseline HbA1c Mean=8 2 Patients taking the combination therapy achieved a significantly lower HbA1c than those taking either drug alone as monotherapy Slide Metformin Glyburide Initial Therapy Distribution of HbA1c at 20 Weeks And indeed more than 66 of those taking the combination therapy achieved a HbA1c of less than 7 Slide
slide64 jpg
drugs when combined were less than when given as monotherapy and that 61 of the patients taking the 1 25 mg 250 mg strength of glyburide metformin received one to two tablets per day Slide Metformin Glyburide Initial Therapy Change from Baseline HbA1c Mean=8 2 Patients taking the combination therapy achieved a significantly lower HbA1c than those taking either drug
slide66 jpg
Slide Metformin Glyburide Initial Therapy Distribution of HbA1c at 20 Weeks And indeed more than 66 of those taking the combination therapy achieved a HbA1c of less than 7 Slide Glyburide Metformin Initial Therapy Postprandial Glucose Excursion This next graph shows the PPG excursions in subjects at baseline and at the end of the study The bottom of each bar
slide56 jpg
levels This usually results in some improvement but generally we fail to reach our goal despite the addition of the second drug after some length of time of treating patients with one drug Slide Sulfonylurea and Metformin Combination Therapy Effect on HbA1c In this next graphic the combination of glyburide and metformin was more effective than either glyburide or metformin
slide57 jpg
Sulfonylurea and Metformin Combination Therapy Effect on HbA1c In this next graphic the combination of glyburide and metformin was more effective than either glyburide or metformin alone Slide Mean Change in HbA1c and FPG at Week 12 Produced by Addition of Repaglinide to Metformin Similarly if we add repaglinide to patients taking metformin we will obtain an additional
001 jpg
Glyburide is used to treat a type of diabetes called Type 2 Diabetes It is part of a group of medicines called Sulfonylureas that help insulin get into the cells where it can work properly
slide67 jpg
significantly reduced in the metformin and the glyburide metformin combination treatment groups when compared with a placebo and glyburide alone shown on the right hand side of the graphic Slide Glyburide Metformin Initial Therapy Frequency of Hypoglycemic Symptoms This graphic summarizes the percent of patients reporting symptoms of hypoglycemia The frequency of symptomatic
slide00 jpg
Slide The Evolution of Diabetes Therapy Addressing Multiple Defects Richard S Beaser MD So accepting the trend for more aggressive therapies how do we select specific medications Earlier
sanofi logo jpg
Sanofi has reported positive results for Acomplia for type II diabetes Acomplia has been tested for weight loss but this is the first study in which the drug was tested by itself as a
MKPerez jpg
Katherine s Birthstory Type II Diabetes Pumper AKA MKPerez Bryan Andrew Born 3 54 am on Saturday May 31st 2003 at 36 weeks and 6 days
email this page
print this page
bookmark this page
feedback on this page
